- Home
- KOPN vs LUNG Comparison
KOPN vs LUNG Comparison
Compare KOPN & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KOPN
- LUNG
- Stock Information
- Founded
- KOPN 1984
- LUNG 1995
- Country
- KOPN United States
- LUNG United States
- Employees
- KOPN N/A
- LUNG N/A
- Industry
- KOPN Semiconductors
- LUNG Industrial Specialties
- Sector
- KOPN Technology
- LUNG Health Care
- Exchange
- KOPN Nasdaq
- LUNG Nasdaq
- Market Cap
- KOPN 282.1M
- LUNG 299.3M
- IPO Year
- KOPN 1992
- LUNG 2020
- Fundamental
- Price
- KOPN $1.36
- LUNG $7.85
- Analyst Decision
- KOPN Strong Buy
- LUNG Strong Buy
- Analyst Count
- KOPN 4
- LUNG 7
- Target Price
- KOPN $2.63
- LUNG $12.64
- AVG Volume (30 Days)
- KOPN 2.3M
- LUNG 464.2K
- Earning Date
- KOPN 05-13-2025
- LUNG 04-30-2025
- Dividend Yield
- KOPN N/A
- LUNG N/A
- EPS Growth
- KOPN N/A
- LUNG N/A
- EPS
- KOPN N/A
- LUNG N/A
- Revenue
- KOPN $44,266,305.00
- LUNG $83,789,000.00
- Revenue This Year
- KOPN $21.20
- LUNG $17.96
- Revenue Next Year
- KOPN $13.55
- LUNG $18.35
- P/E Ratio
- KOPN N/A
- LUNG N/A
- Revenue Growth
- KOPN 0.60
- LUNG 22.01
- 52 Week Low
- KOPN $0.56
- LUNG $5.46
- 52 Week High
- KOPN $2.17
- LUNG $10.01
- Technical
- Relative Strength Index (RSI)
- KOPN 47.23
- LUNG 52.84
- Support Level
- KOPN $1.32
- LUNG $7.65
- Resistance Level
- KOPN $1.48
- LUNG $8.12
- Average True Range (ATR)
- KOPN 0.13
- LUNG 0.56
- MACD
- KOPN 0.01
- LUNG -0.06
- Stochastic Oscillator
- KOPN 64.71
- LUNG 46.86
About KOPN Kopin Corporation
Kopin Corp is a provider of high-performance application-specific optical solutions consisting of high-resolution microdisplays and optics, subassemblies, and headsets. It serves soldiers, avionics, armored vehicles training and simulation military applications, and others. Its product portfolio includes Microdisplays, Spatial Light Modulators, Optical Modules, Medical, Training, and Simulation. Geographically, it derives a majority of its revenue from the Americas and also has a presence in Asia-Pacific; Europe, and Other Countries.
About LUNG Pulmonx Corporation
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.